Memory and Attention Adaptation Training

A Brief Cognitive Behavioral Therapy for Cancer Survivors: Clincian Manual
Erscheinungsjahr 2021
ISBN: 978-0-19-752157-1
Verlag: Oxford University Press

Buch, Englisch, 192 Seiten, Print PDF, Format (B × H): 175 mm x 257 mm, Gewicht: 386 g

Cancer-related cognitive impairment (CRCI) may affect nearly half of all cancer survivors and can persist for years after completing cancer treatment. Memory and Attention Adaptation Training (MAAT) is a cognitive-behavioral therapy offering evidence-based, nonpharmacological treatment of this common survivorship condition. Organized into a session-by-session Clinician Manual and related Survivor Workbook, MAAT is conducted in eight treatment visits and has been demonstrated effective when delivered through telehealth technology, so survivors can readily fit MAAT into their busy lives. The MAAT Clinician Manual provides a clearly written summary of the scientific literature on CRCI and detailed guidance for each visit, including an agenda outline, in-depth discussion, and accompanying fidelity checklist in the appendix. Designed to be used in conjunction with the Survivor Workbook, the Clinician Manual also includes the full text of the workbook in a separate appendix, giving clinicians convenient one-volume access to the complete material.

Autoren/Hrsg.

Ferguson, Robert

Gillock, Karen

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie

Inhaltsverzeichnis

- Use of This Manual

- Introduction

- Visit 1

- Visit 2

- Visit 3

- Visit 4

- Visit 5

- Visit 6

- Visit 7

- Visit 8

- Appendix 1. Survivor Workbook

- Appendix 2. Treatment Fidelity Checklists

- Appendix 3. Progressive Muscle Relaxation (PMR) Protocol

- References

Über Autor(innen)

Robert J. Ferguson, PhD, is a clinical psychologist and Assistant Professor of Medicine with the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center. His clinical and research interests are the treatment of cognitive effects of cancer, cancer survivorship and palliative care. He is the author of numerous peer reviewed research articles and book chapters on treatment of cancer-related cognitive impairment and other topics related to the field of behavioral medicine. His research has been funded by grants from the National Cancer Institute, NIH Office of Research on Women's Health, and private foundations.

Karen Lee Gillock, PhD, is a clincial psychologist licensed in Cognitive-Behavioral Therapy based in Lebanon, New Hampshire.